Viewing Study NCT07419633

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-06-08 @ 1:31 AM
Study NCT ID: NCT07419633
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-19
First Post: 2026-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Muscle View
None Cognitive Functioning View
None Geriatric View
None Ageing and Geriatric Health View
None Ageing View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Health View
None Muscle View
None Cognitive View
None Memory View
None natural product View
None ageing View
None natural View
None supplement View
None preservation View